Yield10 Bioscience (NASDAQ:YTEN) Share Price Passes Above 200-Day Moving Average of $1.02

Share on StockTwits

Yield10 Bioscience Inc (NASDAQ:YTEN)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $1.02 and traded as high as $0.88. Yield10 Bioscience shares last traded at $0.81, with a volume of 79,956 shares traded.

A number of analysts have weighed in on YTEN shares. Maxim Group reaffirmed a “buy” rating and set a $3.00 price objective on shares of Yield10 Bioscience in a research report on Friday, May 31st. Aegis reaffirmed a “buy” rating and set a $2.00 price objective on shares of Yield10 Bioscience in a research report on Tuesday, August 13th. Zacks Investment Research cut Yield10 Bioscience from a “hold” rating to a “sell” rating in a research report on Saturday, August 17th. Finally, National Securities reaffirmed a “buy” rating and set a $5.00 price objective on shares of Yield10 Bioscience in a research report on Tuesday, August 20th.

The business has a 50-day simple moving average of $0.92 and a two-hundred day simple moving average of $1.02. The company has a debt-to-equity ratio of 1.17, a quick ratio of 3.33 and a current ratio of 3.33. The company has a market capitalization of $10.65 million, a price-to-earnings ratio of -0.88 and a beta of 3.21.

Yield10 Bioscience (NASDAQ:YTEN) last posted its quarterly earnings data on Monday, August 12th. The specialty chemicals company reported ($0.15) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.06. Yield10 Bioscience had a negative return on equity of 145.61% and a negative net margin of 1,320.21%. The company had revenue of $0.32 million during the quarter. Research analysts predict that Yield10 Bioscience Inc will post -0.66 EPS for the current fiscal year.

A hedge fund recently raised its stake in Yield10 Bioscience stock. Renaissance Technologies LLC grew its holdings in Yield10 Bioscience Inc (NASDAQ:YTEN) by 9.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 478,176 shares of the specialty chemicals company’s stock after buying an additional 41,500 shares during the quarter. Renaissance Technologies LLC owned about 3.83% of Yield10 Bioscience worth $463,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 7.80% of the company’s stock.

About Yield10 Bioscience (NASDAQ:YTEN)

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The company, through its Smart Carbon Grid for Crops and T3 platforms, is involved in improving fundamental crop yield through enhanced photosynthetic carbon capture, as well as increased carbon utilization efficiency to increase seed yield.

Featured Article: Technical Analysis

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.